Financials
2023
Almonty Announces the Filing of its Audited Annual Consolidated Financial Statements, MD&A & AIF for the Year Ended December 31, 2023 and $2.2M in Positive EBITDA from Mining Operations
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Nine Months Ended September 30, 2023 and $1.74M in Positive EBITDA from Mining Operations
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Six Months Ended June 30, 2023
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three Months Ended March 31, 2023
Q4 December 31, 2023 & 2022 Financial Statements
Q4 December 31, 2023 MD&A
Q3 September 30, 2023 Financial Statements
Q3 September 30, 2023 MD&A
Q2 June 30, 2023 Financial Statements
Q2 June 30, 2023 MD&A
Q1 March 31, 2023 Financial Statements
Q1 March 31, 2023 MD&A
2022
Almonty Announces the Filing of its Audited Annual Consolidated Financial Statements, MD&A & AIF for the Year Ended December 31, 2022 and $3.8M in Positive EBITDA from Mining Operations
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three and Nine Months Ended September 30, 2022 and another Quarter of Positive EBITDA from Mining Operations
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three and Six Months Ended June 30, 2022
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three Months Ended March 31, 2022
Q4 December 31, 2022 & 2021 Financial Statements
Q4 December 31, 2022 MD&A
Q3 September 30, 2022 Financial Statements
Q3 September 30, 2022 MD&A
Q2 June 30, 2022 Financial Statements
Q2 June 30, 2022 MD&A
Q1 March 31, 2022 Financial Statements
Q1 March 31, 2022 MD&A
2021
Almonty Announces the Filing of its Audited Consolidated Financial Statements, MD&A and AIF for the Year Ended December 31, 2021
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three & Nine Months Ended September 30, 2021
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Six Months Ended June 30, 2021
Almonty Announces the Filing of its Unaudited Interim Condensed Consolidated Financial Statements and MD&A for the Three Months Ended March 31, 2021
Q4 December 31, 2021 Financial Statements
Q4 December 31, 2021 MD&A
Q3 September 30, 2021 Financial Statements
Q3 September 30, 2021 MD&A
Q2 June 30, 2021 Financial Statements
Q2 June 30, 2021 MD&A
Q1 March 31, 2021 Financial Statements
Q1 March 31, 2021 MD&A
2020
Almonty Announces The Filing Of Its Audited Annual Consolidated Financial Statements, MD&A and AIF For The Year Ended December 31, 2020
Interim Condensed Consolidated Financial Statements For the Three and Nine Months Ended September 30, 2020 and 2019
Management’s Discussion and Analysis For the Three and Nine Months Ended September 30, 2020
Almonty Announces Positive Q1-2020 EBITDA From Mining Operations and the Filing of its Unaudited Interim Consolidated Financial Statements And MD&A For The 3-Months Ended March 31, 2020
Almonty announces positive $16,440,000 annual EBITDA from mining operations before non-cash impairment charge and the filing of its audited annual financial statements and MD&A for the fifteen months ended December 31, 2019
2019
Almonty Achieves Positive EBITDA From Mining Operations of $3,263,000 in Q3 of FY 2019
Management’s Discussion and Analysis For the Three and Nine Month Periods Ended June 30, 2019
Interim Condensed Consolidated Financial Statements For the Three and Nine Months Ended June 30, 2019 and 2018 (UNAUDITED)
Almonty achieves positive EBITDA of $10,243,000 from mining operations and net income of $0.04 per share in Q1 of FY 2019
Q5 December 31, 2019 Financial Statements
Q5 December 31, 2019 MD&A
Q4 September 30, 2019 Financial Statements
Q4 September 30, 2019 MD&A
Q3 June 30, 2019 Financial Statements
Q3Â June 30, 2019 MD&A
Q2 March 31, 2019 Financial Statements
Q2 March 31, 2019 MD&A
Q1 December 31, 2018 Financial Statements
Q1 December 31, 2018 MD&A
2018
Almonty announces positive $28,472,000 annual EBITDA from mining operations before non-cash impairment charge and the filing of its audited annual financial statements and MD&A for the year ended September 30, 2018
2017
Annual September 30, 2017 Financial Statements
Annual September 30, 2017 MD&A
Annual Information Form for September 30, 2017
Q3Â June 30, 2017 Financial Statements
Q3Â June 30, 2017 MD&A
Q2 March 31, 2017 Financial Statements
Q2 March 31, 2017 MD&A
Q1 December 31, 2016 Financial Statements
Q1 December 31, 2016 MD&A
2016
Annual September 30, 2016 Financial Statements
Annual September 30, 2016 MD&A
Annual Information Form for September 30, 2016
Q3 June 30, 2016 Financial Statements
Q3 June 30, 2016 MD&A
Q2 March 31, 2016 Financial Statements
Q2 March 31, 2016 MD&A
Q1 December 31, 2015 Financial Statements
Q1 December 31, 2015 MD&A
2015
Annual September 30, 2015 Financial Statements
Annual September 30, 2015 MD&A
Annual Information Form for September 30, 2015
Q3 June 30, 2015 Financial Statements
Q3 June 30, 2015 MD&A
Q2 March 31, 2015 Financial Statements
Q2 March 31, 2015 MD&A
Q1 December 31, 2014 Financial Statements
Q1 December 31, 2014 MD&A
2013
Annual September 30, 2013 Financial Statements
Annual September 30, 2013 MD&A
Annual Information Form for September 30, 2013
Q3 June 30, 2013 Financial Statements
Q3 June 30, 2013 MD&A
Q2 March 31, 2013 Financial Statements
Q2 March 31, 2013 MD&A
Q1 December 31, 2012 Financial Statements
Q1 December 31, 2012 MD&A
If you are a shareholder of Almonty Industries Inc. and have questions regarding:
- Change of Address and/or Name
- Transfer of Shares
- Consolidation of Share Certificates
- Replacement of Lost Share Certificates
- Estate Transfers
Contact the Company’s transfer agent directly at:
COMPUTERSHARE INVESTOR SERVICES INC.
510 Burrard Street, 2nd Floor
Vancouver, BC
V6C 3B9
Toll Free:Â 800 564 6253
Toll:Â +1 (514) 982 7555
Fax Number:Â +1 (514) 982 7635 / +1 (888) 453 0330